InvestorsHub Logo
Followers 5
Posts 468
Boards Moderated 0
Alias Born 10/21/2014

Re: None

Monday, 01/23/2017 12:11:35 PM

Monday, January 23, 2017 12:11:35 PM

Post# of 76520
I can't find a flaw with this company, besides the impending name change. And that's not a negative to a savvy investor, it just shows how undervalued this stock truly is and how you can get in before the entire MJ sector finds out Thursday. When investors wake up and realize they are passing an opportunity to buy into a "legit company" with "legit profits" they will be kicking themselves for not getting in earlier. Oh and did I forget to mention CBD derived from hemp is 100% leagl nation wide unlike maijuana. It's medical benefits are unmatch and if you've been followinig the MJ sector you'd noticed companies with medical properties are the biggest gainers and also have less volatility. With a name like ENDO BIOSCIENCES, I'd also like to believe they are setting this to not only go to previous highs, but to crush them and show that hemp & CBD are here to stay and are the future medicines going into the 21st century. Thursday is the deadline, but look for the steady up climb all week into the conference call/earnings